NewGenIVF Commits Additional $4M to K25.ai, Total Investment Reaches $6M
NewGenIVF Group has committed an additional $4M strategic investment in K25.ai, an AI-native livestreaming and watch-to-predict prediction market platform purpose-built for Asia-Pacific, bringing NewGen's total strategic investment in K25.ai to $6M at an implied valuation of $100M. As part of the expanded strategic alignment, K25.ai Founder and CEO Andy Cheung is expected to lead NewGen's Digital Asset Treasury Strategy. The investment comes as NewGen launches its Digital Asset Treasury Strategy, with K25.ai expected to serve as a strategic asset within NewGen's broader exposure to AI-powered prediction market infrastructure. NewGen has invited K25.ai Founder and CEO Andy Cheung, together with two other K25.ai co-founders, to join NewGen's Board of Directors as Non-Executive Directors. Cheung is expected to lead NewGen's Digital Asset Treasury Strategy and strategic allocation initiatives. K25.ai is preparing for its upcoming product launch as waitlist users now exceed 35,000. Bernstein projects global prediction market trading volumes could reach approximately $1T by 2030, up from approximately $51B in 2025.
Trade with 70% Backtested Accuracy
Analyst Views on NIVF
About NIVF
About the author

- Funding Completion: K25.ai successfully closes its $10 million Pre-A funding round at a $100 million valuation, providing strategic support for its product launch and regional expansion, marking a significant growth potential in the Asia-Pacific market.
- Investor Participation: NewGen IVF Group increases its stake in K25.ai to 10% through an additional $4 million investment, which not only enhances its economic participation but also strengthens strategic alignment for future collaborations.
- Market Positioning: K25.ai, as a platform that integrates livestreaming, AI market creation, and real-time community engagement, is focused on establishing an innovative information market in the Asia-Pacific region, expected to attract more investor interest and participation.
- Future Outlook: K25.ai has initiated its Series A fundraising to accelerate product launch and market expansion, which is anticipated to further drive its market share and brand influence in the Asia-Pacific region.
- Increased Strategic Investment: NewGenIVF Group's strategic investment in K25.ai has risen to $6 million, with an additional $4 million bringing K25.ai's implied valuation to $100 million, indicating strong confidence in its growth potential.
- Leadership Role Confirmed: K25.ai founder and CEO Andy Cheung is set to lead NewGen's Digital Asset Treasury Strategy, highlighting K25.ai's critical role in NewGen's digital asset strategy, which may drive business integration and innovation.
- Board Expansion: NewGen has invited Cheung and two other K25.ai co-founders to join its board as non-executive directors, enhancing K25.ai's governance structure within NewGen and likely facilitating strategic synergies and resource sharing.
- Positive Market Reaction: NIVF shares rose by 11%, reflecting market optimism regarding the investment and its potential returns, which may further enhance NewGen's market position in the digital asset sector.
- Stake Increase: NewGen has increased its stake in K25.ai to 6% through an additional $4 million investment, split evenly between cash and newly issued shares, reflecting the company's strong confidence in the digital asset market.
- Digital Asset Strategy: NewGen has formally adopted a Digital Asset Treasury strategy aimed at selectively acquiring high-quality digital assets like Bitcoin and Solana to enhance its reserve base and support long-term growth, further solidifying its position in the digital economy.
- Leadership Team Enhancement: NewGen plans to invite K25.ai founder Andy Cheung and two other co-founders to its Board of Directors to leverage their extensive experience in digital assets and technology, driving the company's strategic execution and market expansion.
- Optimistic Market Outlook: NewGen's 6% stake in K25.ai is currently valued at approximately $6 million, exceeding the company's market capitalization, and with the acceleration of global adoption of prediction markets, NewGen believes K25.ai's valuation has significant upside potential, directly benefiting its balance sheet.
- Equity Acquisition: NewGen has executed a Share Purchase Agreement to acquire a 2% equity stake in K25.ai for $2 million, implying a $100 million valuation, with the option to increase its ownership to 10%, strategically positioning NewGen in the emerging prediction market.
- Exclusive Agency Agreement: NewGen is appointed as K25.ai's exclusive agency partner for selected APAC markets, expected to create a high-margin commercial growth channel for NewGen, with an initial three-year term and renewal potential.
- Market Opportunity: According to Bernstein research, prediction market volumes are projected to reach approximately $1 trillion by 2030, up from about $51 billion in 2025, indicating significant growth potential in this sector.
- APAC Market Advantages: The digital economy, mobile-first infrastructure, and strong gaming and esports communities in the APAC region provide a compelling foundation for K25.ai's localized prediction market platform, with NewGen's investment further driving this strategic initiative.
- Strategic Investment Agreement: NewGenIVF has entered into a strategic investment agreement with K25.ai, making an initial investment of $2 million at a $100 million valuation, positioning NewGenIVF within the rapidly growing AI and live-streaming market.
- Investment Option: NewGenIVF has the option to increase its investment to $10 million, which, if fully exercised, will further enhance its market influence in the Asia-Pacific region, particularly in the prediction market sector.
- Exclusive Agency Agreement: NewGenIVF will act as the exclusive agent for K25.ai in markets such as Thailand, Singapore, and Japan, with expectations to earn commissions based on gross profits from introduced customers, creating new commercial revenue streams.
- Board Nomination: K25.ai will nominate three independent director candidates, with NewGenIVF's board expected to expand from five to eight members, enhancing corporate governance and decision-making capabilities.
- Net Profit Surge: For the fiscal year ending December 31, 2025, NewGenIvf reported a net profit of $9.9 million, indicating a significant increase compared to 2024, reflecting the company's strong market performance and enhanced profitability.
- Substantial Asset Growth: As of December 31, 2025, total assets reached $32.7 million, a remarkable rise from $3.6 million in 2024, showcasing the company's success in business expansion and capital management.
- Increased Asset Value per Share: The asset value per share stood at $135.9 in 2025, demonstrating effective strategies in asset management and shareholder value creation, which bolsters investor confidence.
- Significant Acquisition Value: In July 2025, the company completed the acquisition of advanced cytometry intellectual property, independently valued at $17.9 million by a big-four accounting firm, resulting in a bargain purchase gain of $19.2 million, further solidifying the company's market position.







